Business & Finance
Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation
5 November 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) and UK-based molecular sensing technology company Oxford Nanopore Technologies (LON:ONT) on Wednesday announced the ...
Amgen announces Q4 2025 dividend
3 November 2025 - US-based biopharmaceutical company Amgen (NASDAQ:AMGN) announced on Friday a dividend of USD2.38 per share for the fourth quarter of 2025.This amount is unchanged from Amgen's p...
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
31 October 2025 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) announced on Friday it has been awarded a new and expanded procurement framework contract by the European Commission thr...
Perrigo to pay quarterly dividend of USD0.290 per share
30 October 2025 - Perrigo Company plc (NYSE: PRGO), an American-Irish global provider of consumer health products, on Wednesday announced a quarterly dividend of USD0.290 per share.This amount is unch...
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
29 October 2025 - Life science and clinical research company Thermo Fisher Scientific Inc (NYSE:TMO) on Wednesday announced an agreement to acquire Clario Holdings Inc, a provider of endpoint data sol...
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
27 October 2025 - Nanoform Finland Plc (Nasdaq First North Growth Market: NANOFH, NANOFS), a medicine performance-enhancing company, on Monday announced a partnership with specialty pharma company Rev...